Clostridioides difficile modulates inflammation and stem cell functions in the infant gut

Tens of thousands of scientists, clinicians, and ordinary citizens warned OMB about putting political appointees in charge of which research gets funded.

Sweeping proposed rule, now open for comments, would also restrict foreign collaborations and remove federal funding for open-access fees

Join us at the Keystone Symposia on Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection, May 2026, in Breckenridge, with field leaders!

The Theriot Lab is seeking a motivated and detail-oriented Research Specialist for a 1 year appointment. This role is ideal for a candidate looking to dive deep into microbiology research, focusing on...

Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey.

YouTube video by KeystoneSymposia

Mucosal administration of a multivalent, adjuvanted vaccine against Clostridioides difficile promoted bacterial clearance and protected against morbidity, mortality, tissue damage and recurrence ...

The gut’s microbial ecosystem produces diverse metabolites that actively shape neural, immune, and endocrine function. Join leading researchers on December 12 as they share new discoveries into these ...

A bile acid-bound structure of toxin TcdB revealed the mechanism of inhibition and guided the design of a synthetic bile acid that alleviated Clostridioides difficile infection in mice.

Clostridioides difficile infection (CDI) is an urgent public health threat in the United States, resulting on an annual basis in over half a million cases, more than 29,000 deaths, and $4.8 billion in...

Het in Leiden ontwikkelde antibioticum EVG7 slaagt erin om met een minimale dosis de gevaarlijke darmbacterie C. difficile te bestrijden. Bovendien komt de bacterie minder gemakkelijk terug, wat bij b...

Treatment of Clostridioides difficile infections (CDI) with vancomycin is associated with high relapse rates. In this study, the experimental glycopeptide antibiotic EVG7 was found to effectively treat CDI without relapse in a murine model of recurrent CDI.

Treatment of Clostridioides difficile infections (CDI) with vancomycin is associated with high relapse rates. In this study, the experimental glycopeptide antibiotic EVG7 was found to effectively treat CDI without relapse in a murine model of recurrent CDI.

A former NIH official says she was removed after clashes over vaccines, accusing RFK Jr. and his deputies of posing "a substantial and specific danger to public health and safety."

UNC-Chapel Hill is navigating a significant $126 million reduction in federal grant funding compared to last fiscal year.

A postdoctoral scientist position (1+ years) is available in Prof. Casey Theriot’s group at North Carolina State University College of Veterinary Medicine (NCSU CVM).Duties and ResponsibilitiesThe suc...

A postdoctoral scientist position (1+ years) is available in Prof. Casey Theriot’s group at North Carolina State University College of Veterinary Medicine (NCSU CVM).Duties and ResponsibilitiesThe suc...

Mass spectrometry data mining tools enabled the creation of an MS/MS spectral library containing hundreds of N-acyl lipids, including conjugates with short-chain fatty acids. This resource enabled the...

The widespread terminations at the Department of Health and Human Services have drawn questions about the functioning of key health programs.

Clostridioides difficile epidemiology is rapidly evolving, and understanding the factors that contribute to one’s risk of C. difficile infection (CDI) is urgently needed. Based on our observations in ...

YouTube video by KFF Health News

Join us at the Keystone Symposia on Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection, May 2026, in Breckenridge, with field leaders!